Background: The prenatal evaluation of skeletal dysplasias is challenging. Ultrasound (US) has limited sensitivity in evaluating these abnormalities. Low-dose fetal computed tomography (CT) is a helpful adjunct in evaluating the fetus with severe abnormalities, but its use is limited by lack of data on normal fetal bone length. Objective: To obtain CT measurements of fetal long bones and to compare published US normative bone length measures to examine their similarity. Methods: A retrospective search of a radiographic database for gravid patients with CT of the abdomen/pelvis for acute maternal abdomen was performed. Fetal long bone measurements were plotted against gestational age (GA)/standard US measurements. Regression coefficients were calculated (p values <0.05 were considered significant). Bland-Altman plots were constructed to identify any systematic difference between CT and US bone length measures. Results: Twenty-five cases met the inclusion criterion of fetal GA 16-39 weeks. The length of long bones increased with GA, with strong R2 values for each measurement. Plots of CT measurements against published 50th percentile sonographic values for age also showed strong and significant correlations, suggesting that values may be used interchangeably, a conclusion further substantiated by the Bland-Altman analyses. Conclusion: A CT database for fetal long bone length is presented which can be used to evaluate the fetus with abnormal bones. Additionally we have established a strong correlation between measured fetal CT long bone values and the published 50th percentile normal values for US, which allows the interpreting radiologist to extrapolate CT measurements to US values in the evaluation of fetal bone length.

Keywords:
Low-dose fetal computed tomography, Skeletal dysplasia, Prenatal diagnosis
1.
Doray B, Favre R, Viville B, Langer B, Dreyfus M, Stoll C: Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Ann Genet 2000;43:163-169.
2.
Parilla BV, Leeth EA, Kambich MP, Chilis P, MacGregor SN: Antenatal detection of skeletal dysplasias. J Ultrasound Med 2003;22:255-258; quiz 259-261.
3.
Victoria T, Epelman M, Coleman BG, Horii S, Oliver ER, Mahboubi S, Khalek N, Kasperski S, Edgar JC, Jaramillo D: Low-dose fetal CT in the prenatal evaluation of skeletal dysplasias and other severe skeletal abnormalities. AJR Am J Roentgenol 2013;200:989-1000.
4.
Victoria T, Epelman M, Bebbington M, Johnson AM, Kramer S, Wilson RD, Jaramillo D: Low-dose fetal CT for evaluation of severe congenital skeletal anomalies: preliminary experience. Pediatr Radiol 2012;42(suppl 1): S142-S149.
5.
Miyazaki O, Nishimura G, Sago H, Horiuchi T, Hayashi S, Kosaki R: Prenatal diagnosis of fetal skeletal dysplasia with 3D CT. Pediatr Radiol 2012;42:842-852.
6.
Krakow D, Lachman RS, Rimoin DL: Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet Med 2009;11:127-133.
7.
Schramm T, Gloning KP, Minderer S, Daumer-Haas C, Hörtnagel K, Nerlich A, Tutschek B: Prenatal sonographic diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol 2009;34:160-170.
8.
Rimoin DL, Cohn D, Krakow D, Wilcox W, Lachman RS, Alanay Y: The skeletal dysplasias: clinical-molecular correlations. Ann NY Acad Sci 2007;1117:302-309.
9.
Nyberg DA: Diagnostic Imaging of Fetal Anomalies. Philadelphia, Lippincott Williams and Wilkins, 2003.
10.
McCollough CH, Schueler BA, Atwell TD, Braun NN, Regner DM, Brown DL, LeRoy AJ: Radiation exposure and pregnancy: when should we be concerned? Radiographics 2007;27:909-917; discussion 917-918.
11.
Taneja R, Dighe M, Kanal KM, Richardson ML, Mitsumori LM, Dubinsky TJ: Utility of multiplanar and three-dimensional reconstructions from computed tomography performed for maternal indications for visualizing fetal anatomy and estimating gestational age. J Comput Assist Tomogr 2011;35:446-453.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.